diabetes
Showing NaN - NaN of 86
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Enrolling by invitation
- Diabetes
- +4 more
-
Phoenix, Arizona
- +26 more
Jan 19, 2023
TEWL Biomarker Study for Diabetic Foot Ulcer Recurrence
Active, not recruiting
- Diabetes
- +4 more
- Observational
-
San Francisco, California
- +5 more
Jan 20, 2023
Stroke Incidence and Risk Factors in a Tri-ethnic Region
Completed
- Diabetes
- +4 more
-
Miami, FloridaUniversity of Miami
Jan 10, 2023
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +105 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Lancaster, California
- +104 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +107 more
Jul 11, 2022
Diabetes Trial in United States (Blood glucose meter, Eversense CGM System)
Recruiting
- Diabetes
- Blood glucose meter
- Eversense CGM System
-
Los Angeles, California
- +15 more
Jun 15, 2022
C-myc Biomarker Study for Diabetic Foot Ulcers
Recruiting
- Diabetes
- +3 more
-
San Francisco, California
- +5 more
Mar 9, 2022
Diabetes Trial in Miami (Human Pancreatic Islet Transplantation)
Recruiting
- Diabetes
- Human Pancreatic Islet Transplantation
-
Miami, Florida
- +1 more
Feb 23, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +3 more
-
Concord, California
- +166 more
Jan 6, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +184 more
Jul 1, 2021
Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- NNC0114-0006
- +2 more
-
La Jolla, California
- +107 more
Mar 10, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- oral placebo
-
Tucson, Arizona
- +102 more
Jan 14, 2021
Diabetes, Senior Syndrome, Frailty Trial in Miami, Sweetwater (Diet, Exercise, Diet and exercise)
Terminated
- Diabetes
- +2 more
- Diet
- +2 more
-
Miami, Florida
- +3 more
Jan 4, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Birmingham, Alabama
- +81 more
Oct 26, 2020
Overweight, Diabetes, PreDiabetes Trial in Worldwide (Gelesis200, Placebo)
Unknown status
- Overweight
- +3 more
- Gelesis200
- Placebo
-
Birmingham, Alabama
- +29 more
Jul 20, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Diabetes, Diabetes, Type 2, Cholesterolemia Trial in United States (Bempedoic acid + Ezetimibe FDC Oral Tablet, Ezetimibe 10 mg
Completed
- Diabetes
- +2 more
- Bempedoic acid + Ezetimibe FDC Oral Tablet
- +3 more
-
Lincoln, California
- +3 more
Apr 8, 2020
Obesity, Metabolic Syndrome, Diabetes Trial in Miami (Recombinant methionyl human leptin)
Completed
- Obesity
- +2 more
- Recombinant methionyl human leptin
-
Miami, FloridaUniversity of Miami, Center on Pharmacogenomics
Feb 11, 2020
Obesity, Metabolic Syndrome, Diabetes Trial in Miami (Recombinant methionyl human leptin)
Completed
- Obesity
- +2 more
- Recombinant methionyl human leptin
-
Miami, FloridaUniversity of Miami Miller School of Medicine, Center on Pharmac
Feb 11, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Semaglutide
- +3 more
-
Anaheim, California
- +118 more
Jan 8, 2020